Tag: Pareto Biotechnologies

On the Move in the Bioeconomy: Pareto Biotechnologies, Vecoplan Integrated Controls

On the Move in the Bioeconomy: Pareto Biotechnologies, Vecoplan Integrated Controls

February 5, 2014 |

In California, Pareto Biotechnologies announced today its appointment of Michael Mendez as its Chief Technology Officer (CTO). “Synthetic biology needs a win, and Pareto’s novel platform has the ability to deliver,” said Mendez. “Our CEO, Jamie Bacher, has assembled the tools and the team required to take synthetic biology and apply not only an innovative […]

Read More

Help, I’ve Fallen and My Enterprise Can’t Get Up: Goldilocks, right-sizing and synth-bio

Help, I’ve Fallen and My Enterprise Can’t Get Up: Goldilocks, right-sizing and synth-bio

December 15, 2013 |

The story of Pareto Biotechnologies, RuBisCo, the pesky failures of evolution, and help for those who have fallen and can’t get up, via a right-sized approach. Not too high a goal, not too low. Not too much reinvention of the genetic code. Not too little. Will Pareto’s approach be “just right”? The odds are good […]

Read More

Breakout Labs funds Pareto Biotechnologies

Breakout Labs funds Pareto Biotechnologies

November 24, 2013 |

In California, Thiel Foundation’s Breakout Labs selected Pareto Biotechnologies for funding. Breakout Labs is a philanthropic revolving fund financed by investor Peter Thiel to promote novel scientific ideas with promising commercial applications, awarding up to $350,000 to early-stage companies with cutting-edge technologies.  Breakout Labs supports these companies in their quest to achieve specific milestones that are necessary […]

Read More